BioCi­na com­pletes takeover of Pfiz­er-owned Aus­tralia plant; Cam­brex adds space at NC site for small mol­e­cules

San Diego CD­MO BioCi­na has fi­nal­ized the fi­nal tran­si­tion of its takeover of an Aus­tralian man­u­fac­tur­ing site to boost its mR­NA op­er­a­tions.

BioCi­na com­plet­ed the ac­qui­si­tion from Pfiz­er-owned Hos­pi­ra Ade­laide, which be­gan in Au­gust 2020. It now will have the abil­i­ty to quick­ly man­u­fac­ture ther­a­pies us­ing plas­mid DNA, a crit­i­cal part of man­u­fac­tur­ing mR­NA vac­cines, CAR-T cell ther­a­pies and vi­ral gene re­place­ment ther­a­pies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER